Índice
Literatura científica selecionada sobre o tema "Transcriptional co-activator with PDZ-Binding motif (TAZ)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Transcriptional co-activator with PDZ-Binding motif (TAZ)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Transcriptional co-activator with PDZ-Binding motif (TAZ)"
Wu, Chia-Lin, Chia-Chu Chang, Tao-Hsiang Yang, et al. "Tubular transcriptional co-activator with PDZ-binding motif protects against ischemic acute kidney injury." Clinical Science 134, no. 13 (2020): 1593–612. http://dx.doi.org/10.1042/cs20200223.
Texto completo da fonteHuang, Yao, Xueqian Ouyang, Jinghua Tan, Zhenyu Meng, Xiuwen Ma, and Yiguo Yan. "The physiological and pathogenic roles of yes-associated protein/transcriptional co-activator with PDZ-binding motif in bone or skeletal motor system-related cells." Cytojournal 22 (February 8, 2025): 13. https://doi.org/10.25259/cytojournal_237_2024.
Texto completo da fonteLiu, Tao, Jiaojiao Zhou, Yanmin Chen, et al. "Genome-Wide Characterization of TAZ Binding Sites in Mammary Epithelial Cells." Cancers 15, no. 19 (2023): 4713. http://dx.doi.org/10.3390/cancers15194713.
Texto completo da fonteSalem and Hansen. "The Hippo Pathway in Prostate Cancer." Cells 8, no. 4 (2019): 370. http://dx.doi.org/10.3390/cells8040370.
Texto completo da fonteTiffon, Camille, Julie Giraud, Silvia Elena Molina-Castro, et al. "TAZ Controls Helicobacter pylori-Induced Epithelial–Mesenchymal Transition and Cancer Stem Cell-Like Invasive and Tumorigenic Properties." Cells 9, no. 6 (2020): 1462. http://dx.doi.org/10.3390/cells9061462.
Texto completo da fonteMAHONEY, William M., Jeong-Ho HONG, Michael B. YAFFE, and Iain K. G. FARRANCE. "The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members." Biochemical Journal 388, no. 1 (2005): 217–25. http://dx.doi.org/10.1042/bj20041434.
Texto completo da fonteChu, Cong-Qiu, and Taihao Quan. "Fibroblast Yap/Taz Signaling in Extracellular Matrix Homeostasis and Tissue Fibrosis." Journal of Clinical Medicine 13, no. 12 (2024): 3358. http://dx.doi.org/10.3390/jcm13123358.
Texto completo da fonteWarren, Janine, Yuxuan Xiao, and John Lamar. "YAP/TAZ Activation as a Target for Treating Metastatic Cancer." Cancers 10, no. 4 (2018): 115. http://dx.doi.org/10.3390/cancers10040115.
Texto completo da fontePark, Sangryong, Ho-Young Lee, Jayoung Kim, et al. "Cerebral Cavernous Malformation 1 Determines YAP/TAZ Signaling-Dependent Metastatic Hallmarks of Prostate Cancer Cells." Cancers 13, no. 5 (2021): 1125. http://dx.doi.org/10.3390/cancers13051125.
Texto completo da fonteLauriola, Angela, Elisa Uliassi, Matteo Santucci, et al. "Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library." Pharmaceutics 14, no. 2 (2022): 391. http://dx.doi.org/10.3390/pharmaceutics14020391.
Texto completo da fonte